Literature DB >> 22024145

The incidence and risk factors of post-infectious irritable bowel syndrome: a meta-analysis.

Cong Dai1, Min Jiang.   

Abstract

BACKGROUND/AIMS: PI-IBS is a common disorder wherein symptoms of IBS begin after acute gastroenteritis. The aims were to assess the relationship of IBS and preceding episodes of gastroenteritis and explore the risk factors.
METHODOLOGY: Electronic databases (1985-2010) were searched to retrieve trials. Outcome measures were incidence of PI-IBS. Review 4.3.1 was used for the statistical analysis and POR and 95% CI as summary statistics were calculated.
RESULTS: Ten studies were assessed for incidence of PI-IBS at last study assessment (POR=6.03; 95% CI 3.58 to 10.13). In subgroup analysis, six studies each were assessed for incidence of PI-IBS at 3 months (POR=8.47; 95% CI 4.85 to 14.76), 6 months (POR=4.58; 95% CI 2.94 to 7.14) and 12 months (POR=6.19; 95% CI 2.82 to 13.58). Four studies were assessed for incidence of PI-IBS at 24-36 months (POR=4.05; 95% CI 3.13 to 5.24).
CONCLUSIONS: The odds of developing IBS are increased after acute gastrointestinal infection. There are many risk factors for the development of PI-IBS including female gender, younger age, severity of the initial gastrointestinal insult, duration of the enteritis and adverse psychological factors.

Entities:  

Mesh:

Year:  2012        PMID: 22024145     DOI: 10.5754/hge10796

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  13 in total

1.  Incidence and predictive factors of irritable bowel syndrome after acute diverticulitis in Korea.

Authors:  Sungmo Jung; Hyuk Lee; Hyunsoo Chung; Jun Chul Park; Sung Kwan Shin; Sang Kil Lee; Yong Chan Lee
Journal:  Int J Colorectal Dis       Date:  2014-09-26       Impact factor: 2.571

2.  A randomized double-blind placebo-controlled trial of a multi-strain probiotic in treatment of symptomatic uncomplicated diverticular disease.

Authors:  Charlotte L Kvasnovsky; Ingvar Bjarnason; Ana Nora Donaldson; Roy A Sherwood; Savvas Papagrigoriadis
Journal:  Inflammopharmacology       Date:  2017-05-20       Impact factor: 4.473

Review 3.  Post-infectious IBS, tropical sprue and small intestinal bacterial overgrowth: the missing link.

Authors:  Uday C Ghoshal; Kok-Ann Gwee
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-05-17       Impact factor: 46.802

4.  Rab5a Promotes Cytolethal Distending Toxin B-Induced Cytotoxicity and Inflammation.

Authors:  Ming-Xian Chen; Yu Chen; Rui Fu; Guo-Qun Mao; Sai-Yue Liu; Tang-Biao Shen
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

5.  Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain.

Authors:  Huijing Wang; Cobi J Heijnen; Cindy T J van Velthoven; Hanneke L D M Willemen; Yoshihiro Ishikawa; Xinna Zhang; Anil K Sood; Anne Vroon; Niels Eijkelkamp; Annemieke Kavelaars
Journal:  J Clin Invest       Date:  2013-11-15       Impact factor: 14.808

6.  Postinfectious functional gastrointestinal disorders: a focus on epidemiology and research agendas.

Authors:  Adam Deising; Ramiro L Gutierrez; Chad K Porter; Mark S Riddle
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-03

7.  Early adverse life events and resting state neural networks in patients with chronic abdominal pain: evidence for sex differences.

Authors:  Arpana Gupta; Lisa Kilpatrick; Jennifer Labus; Kirsten Tillisch; Adam Braun; Jui-Yang Hong; Cody Ashe-McNalley; Bruce Naliboff; Emeran A Mayer
Journal:  Psychosom Med       Date:  2014 Jul-Aug       Impact factor: 4.312

8.  Abdominal pain in ulcerative colitis.

Authors:  Matthew D Coates; Mayank Lahoti; David G Binion; Eva M Szigethy; Miguel D Regueiro; Klaus Bielefeldt
Journal:  Inflamm Bowel Dis       Date:  2013-09       Impact factor: 5.325

9.  Can a mathematical model be used to estimate the contribution of acute gastroenteritis to the overall prevalence of irritable bowel syndrome?

Authors:  Kuck Meng Chong; Andrew Seng Boon Chua
Journal:  J Neurogastroenterol Motil       Date:  2012-04-09       Impact factor: 4.924

10.  Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome?

Authors:  Anna Chiara Piscaglia; Lucrezia Laterza; Valentina Cesario; Viviana Gerardi; Rosario Landi; Loris Riccardo Lopetuso; Giovanni Calò; Giovanna Fabbretti; Massimo Brisigotti; Maria Loredana Stefanelli; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2016-12-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.